Enterprise Value
$75.08 B
$0.000.00%
58 min ago
Summary
- As of February 20, 2025, REGN enterprise value is $75.08 billion, unchanged from the previous trading day.
- Over the past year, REGN enterprise value has dropped by -$29.01 billion (-27.87%).
- REGN enterprise value is now -43.54% below its all-time high of $132.99 billion.
Performance
REGN Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
REGN Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | 0.0% | 0.0% |
| 1 m1 month | +0.1% | +0.1% | +0.4% |
| 3 m3 months | -8.9% | -8.4% | -8.0% |
| 6 m6 months | -43.2% | -43.0% | -42.6% |
| ytdytd | -2.6% | -2.6% | -2.3% |
| 1 y1 year | -27.9% | -28.1% | -27.8% |
| 5 y5 years | +74.6% | +70.5% | +71.6% |
REGN Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -5.7% | $73 B | +2.8% | |
| 3 m | 3-month | $87 B | -14.0% | $73 B | +2.8% |
| 6 m | 6-month | $133 B | -43.5% | $73 B | +2.8% |
| 1 y | 1-year | $133 B | -43.5% | $73 B | +2.8% |
| 3 y | 3-year | $133 B | -43.5% | $60 B | +26.0% |
| 5 y | 5-year | $133 B | -43.5% | $43 B | +74.6% |
| alltime | all time | $133 B | -43.5% | $45 M | >+9999.0% |
Regeneron Pharmaceuticals Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $75.08 B(-2.6%) |
| 2024 | $77.06 B(-19.5%) |
| 2023 | $95.73 B(+21.6%) |
| 2022 | $78.73 B(+15.0%) |
| 2021 | $68.44 B(+31.2%) |
| 2020 | $52.17 B(+28.8%) |
| 2019 | $40.50 B(+1.4%) |
| 2018 | $39.95 B(-1.0%) |
| 2017 | $40.35 B(+3.8%) |
| 2016 | $38.86 B(-31.1%) |
| 2015 | $56.36 B(+34.7%) |
| 2014 | $41.83 B(+52.6%) |
| 2013 | $27.41 B(+62.5%) |
| 2012 | $16.87 B(+231.1%) |
| 2011 | $5.10 B(+70.8%) |
| 2010 | $2.98 B(+60.1%) |
| 2009 | $1.86 B(+53.4%) |
| Date | Value |
|---|---|
| 2008 | $1.21 B(-24.3%) |
| 2007 | $1.61 B(+25.9%) |
| 2006 | $1.27 B(+39.6%) |
| 2005 | $912.88 M(+47.4%) |
| 2004 | $619.25 M(-32.2%) |
| 2003 | $912.86 M(-3.3%) |
| 2002 | $943.83 M(-20.8%) |
| 2001 | $1.19 B(-6.2%) |
| 2000 | $1.27 B(+233.2%) |
| 1999 | $381.04 M(+78.8%) |
| 1998 | $213.16 M(-11.7%) |
| 1997 | $241.47 M(-37.8%) |
| 1996 | $388.23 M(+52.1%) |
| 1995 | $255.20 M(+463.5%) |
| 1994 | $45.29 M(-84.2%) |
| 1993 | $287.24 M(+64.5%) |
| 1992 | $174.64 M(-31.5%) |
| 1991 | $255.05 M |
FAQ
- What is Regeneron Pharmaceuticals enterprise value?
- What is the all time high enterprise value for Regeneron Pharmaceuticals?
- What is REGN enterprise value year-to-date change?
- What is Regeneron Pharmaceuticals enterprise value year-on-year change?
What is Regeneron Pharmaceuticals enterprise value?
The current enterprise value of REGN is $75.08 B
What is the all time high enterprise value for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high enterprise value is $132.99 B
What is REGN enterprise value year-to-date change?
Regeneron Pharmaceuticals enterprise value has changed by -$1.98 B (-2.57%) since the beginning of the year
What is Regeneron Pharmaceuticals enterprise value year-on-year change?
Over the past year, REGN enterprise value has changed by -$29.01 B (-27.87%)